NIAID | Technology Transfer

STABILIZED INFLUENZA HEMAGGLUTININ STEM REGION TRIMERS AND USES THEREOF

Read more about STABILIZED INFLUENZA HEMAGGLUTININ STEM REGION TRIMERS AND USES THEREOF

Switzerland
15727824.3
Filed on 2015-05-27

STABILIZED INFLUENZA HEMAGGLUTININ STEM REGION TRIMERS AND USES THEREOF

Read more about STABILIZED INFLUENZA HEMAGGLUTININ STEM REGION TRIMERS AND USES THEREOF

Belgium
15727824.3
Filed on 2015-05-27

STABILIZED INFLUENZA HEMAGGLUTININ STEM REGION TRIMERS AND USES THEREOF

Read more about STABILIZED INFLUENZA HEMAGGLUTININ STEM REGION TRIMERS AND USES THEREOF

Austria
15727824.3
Filed on 2015-05-27

PREFUSION-STABILIZED LASSA VIRUS GLYCOPROTEIN COMPLEX AND ITS USE

Read more about PREFUSION-STABILIZED LASSA VIRUS GLYCOPROTEIN COMPLEX AND ITS USE

Patent Cooperation Treaty
PCT/US2022/027136
Filed on 2022-04-29

RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS STRAINS WITH MUTATIONS IN THE M2-2 ORF PROVIDING A RANGE OF ATTENUATION PHENOTYPES

Read more about RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS STRAINS WITH MUTATIONS IN THE M2-2 ORF PROVIDING A RANGE OF ATTENUATION PHENOTYPES

US Application 17/721,188
Filed on 2022-04-14

Myelin Oligodendrocyte Glycoprotein, Myelin Basic Protein, and Proteolipid Protein Compositions and Methods of Use

Read more about Myelin Oligodendrocyte Glycoprotein, Myelin Basic Protein, and Proteolipid Protein Compositions and Methods of Use

United Kingdom
16711090.7
Filed on 2016-03-09

Myelin Oligodendrocyte Glycoprotein, Myelin Basic Protein, and Proteolipid Protein Compositions and Methods of Use

Read more about Myelin Oligodendrocyte Glycoprotein, Myelin Basic Protein, and Proteolipid Protein Compositions and Methods of Use

France
16711090.7
Filed on 2016-03-09

Myelin Oligodendrocyte Glycoprotein, Myelin Basic Protein, and Proteolipid Protein Compositions and Methods of Use

Read more about Myelin Oligodendrocyte Glycoprotein, Myelin Basic Protein, and Proteolipid Protein Compositions and Methods of Use

Germany
16711090.7
Filed on 2016-03-09

METHODS OF DIAGNOSING AND TREATING CD55 DEFICIENCY, HYPERACTIVATION OF COMPLEMENT, ANGIOPATHIC THROMBOSIS AND PROTEIN LOSING ENTEROPATHY (CHAPLE), A NEWLY IDENTIFIED ORPHAN DISEASE

Read more about METHODS OF DIAGNOSING AND TREATING CD55 DEFICIENCY, HYPERACTIVATION OF COMPLEMENT, ANGIOPATHIC THROMBOSIS AND PROTEIN LOSING ENTEROPATHY (CHAPLE), A NEWLY IDENTIFIED ORPHAN DISEASE

United Kingdom
17784438.8
Filed on 2017-09-13

METHODS OF DIAGNOSING AND TREATING CD55 DEFICIENCY, HYPERACTIVATION OF COMPLEMENT, ANGIOPATHIC THROMBOSIS AND PROTEIN LOSING ENTEROPATHY (CHAPLE), A NEWLY IDENTIFIED ORPHAN DISEASE

Read more about METHODS OF DIAGNOSING AND TREATING CD55 DEFICIENCY, HYPERACTIVATION OF COMPLEMENT, ANGIOPATHIC THROMBOSIS AND PROTEIN LOSING ENTEROPATHY (CHAPLE), A NEWLY IDENTIFIED ORPHAN DISEASE

France
17784438.8
Filed on 2017-09-13

Subscribe to NIAID